US 8318177
Viral chemokine-antigen fusion proteins
granted A61KA61K2039/505A61K39/39541
Quick answer
US patent 8318177 (Viral chemokine-antigen fusion proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K39/39541, A61P, A61P31/12